Observational studyJournal of diabetes investigation2021

On-label use of sodium-glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetes.

Takeshi Horii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.